Program in Cancer Research Outcomes Training (PCORT)

描述（由申请人提供）：我们要求继续资助非常成功的丹娜-法伯/哈佛癌症中心（DF/HCC）癌症结局研究培训（PCRT）计划。PCOT是一个独特的，基于医学的，跨学科的计划，致力于培养癌症结果和医疗保健提供研究的领导者的目标，特别关注癌症预防和控制。我们相信，PCRT有足够的研究和培训机会，提供全面的研究培训经验，我们的成功-以及我们的学员的成功-证明这一要求继续资助。 资金将允许继续招聘2名新的医学博士。和/或博士培训生和1名新的博士前培训生每年。由于所有学员在该计划中至少花费2年时间，因此我们将始终保持该计划中的6名学员。我们将招募具有不同先前研究经验和培训的个人，并将所有学员融入高度协作的研究环境。我们还将积极招募高素质的少数民族和妇女申请人参加该计划。 该计划有3个组成部分：1）专业课程; 2）积极参与其他教学经验; 3）指导，多学科癌症相关成果研究。专业课程包括每周一次的研讨会，包括教学讲座以及学员和教师的“研究进展”演示。合格的学员还参加哈佛临床有效性计划（PCE），这是布里格姆妇女医院、马萨诸塞州总医院、哈佛医学院和哈佛公共卫生学院的联合计划。PCE是一个密集的，为期七周，15学分的课堂计划，包括流行病学和生物统计学必修课程，以及各种选修课。我们鼓励学员报名参加或旁听整个哈佛大学系统中适合其培训水平的额外课程。虚拟医学博士博士后研究员完成硕士学位（M.P.H.）或M.Sc.）在哈佛公共卫生学院。 受训者花费大部分时间在PCOT导师的监督下参与指导的癌症结果研究。个人项目由受训者、他/她的导师和PCRT项目主任达成协议开发，并由PCRT咨询委员会批准。所有项目都是多学科和高度合作的。非常重视团队科学。学员接触到广泛的癌症结果研究方法和主题。 学员在整个过程中和完成课程后接受评估。在成功完成培训计划后，他们将做好充分准备，进行独立的，外部资助的癌症结果研究，并作为多学科研究团队的一部分有效地这样做。

DESCRIPTION (provided by applicant): We request continued funding for the highly successful, Dana-Farber/Harvard Cancer Center (DF/HCC) Program in Cancer Outcomes Research Training (PCORT). PCORT is a unique, curriculum-based, inter-disciplinary program dedicated to the goal of training leaders in cancer outcomes and healthcare delivery research, with a particular focus on cancer prevention and control. We believe that PCORT has sufficient research and training opportunities to provide a comprehensive research training experience, and that our success - and the success of our trainees - justifies this request for continued funding. Funding will allow continued recruitment of 2 new M.D. and/or Ph.D. trainees and 1 new pre-doctoral trainee per year. Because all trainees spend a minimum of 2 years in the Program, we will maintain a total of 6 trainees in the Program at all times. We will recruit individuals wit diverse prior research experience and training, and will integrate all trainees into a highly collaborative research environment. We will also actively recruit highly qualified minority and women applicants to the program. The Program has 3 components: 1) a specialized curriculum; 2) active participation in other didactic experiences; and, 3) mentored, multidisciplinary cancer-related outcomes research. The specialized curriculum involves weekly seminars, including both didactic lectures and "research-in-progress" presentations by trainees and faculty. Appropriately qualified trainees also attend the Harvard Program in Clinical Effectiveness (PCE), a joint Program of Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, and Harvard School of Public Health. The PCE is an intensive, seven-week, 15 credit classroom-based program that includes required courses in epidemiology and biostatistics, as well as a variety of electives. Trainees are encouraged to enroll in or may audit additional courses throughout the Harvard University system that are appropriate for their level of training. Virtuall all M.D. post-doctoral fellows complete a Masters Degree (M.P.H. or M.Sc.) at the Harvard School of Public Health. Trainees spend the largest part of their time participating in mentored cancer outcomes research under the supervision of PCORT mentors. Individual projects are developed by agreement among the trainee, his/her mentors and the PCORT Program Director, and approved by the PCORT Advisory Committee. All projects are multidisciplinary and highly collaborative. There is a strong emphasis on team science. Trainees are exposed to a broad range of cancer outcomes research methods and topics. Trainees are evaluated throughout and upon completion of the Program. After successful completion of the training program, they will be well prepared to conduct independent, externally funded, cancer outcomes research, and to do so effectively as part of a multidisciplinary research team.